Yes, right now there are an abundance of doses secondary to lack of knowledge. This Phase III trial as the article says will likely move the needle. At this time, I would recommend anyone who has moderate disease get this. If you have comorbidities and mild disease, get this ASAP
I’m puzzled how there can be a lack knowledge with something like this. Doctors just too busy to stay informed?